Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Lodoxamide Impurity 1

Lodoxamide Impurity 1 is listed in the pharmaceutical impurity collection under CAS 61313-43-7. Its represented structure has formula C7H4N4O4 and a calculated molecular weight of 208.13 g/mol.

2D chemical structure

N N + O O - H 2 N N + O O -

Chemical identity

Catalog name
Lodoxamide Impurity 1
Common name
Lodoxamide Impurity 1
Chemical name
4-amino-3,5-dinitrobenzonitrile
CAS
61313-43-7
SMILES
N#Cc1cc([N+](=O)[O-])c(N)c([N+](=O)[O-])c1
InChI
InChI=1S/C7H4N4O4/c8-3-4-1-5(10(12)13)7(9)6(2-4)11(14)15/h1-2H,9H2
InChIKey
RGRAGCMUYDRBKB-UHFFFAOYSA-N
Associated API
Lodoxamide

Record ID: Aada2b613b654

Computed properties

C7H4N4O4 Molecular formula
208.133 g/molMolecular weight
208.0233 DaMonoisotopic exact mass
136.09 ŲTopological polar surface area
0.9569 Calculated LogP (Wildman–Crippen)
48.8782 cm³/molMolar refractivity (Wildman–Crippen)
6 countHydrogen-bond acceptors
1 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 6 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 2 4 6 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight208.13319.37
Calculated LogP (Wildman–Crippen)0.956924.70
Topological polar surface area136.0986.23
Hydrogen-bond acceptors675.83
Hydrogen-bond donors138.08
Rotatable bonds (strict)224.16

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC7H4N4O4dimensionless
Molecular weight208.133g/mol
Monoisotopic exact mass208.0233Da
Topological polar surface area136.09Ų
Calculated LogP (Wildman–Crippen)0.9569dimensionless
Molar refractivity (Wildman–Crippen)48.8782cm³/mol
Hydrogen-bond acceptors6count
Hydrogen-bond donors1count
Rotatable bonds (strict)2count
Heavy atoms15count
Heteroatoms8count
Rings1count
Aromatic rings1count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles1count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area82.8348Ų
Valence electrons76count
Radical electrons0count
Bertz complexity455.2489index
Balaban J3.5577index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Lodoxamide Impurity 1

Qualification and safety assessment of Lodoxamide Impurity 1

Explore toxicological qualification of Lodoxamide Impurity 1 and ICH M7 mutagenic impurity assessment of Lodoxamide Impurity 1 for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Lodoxamide Impurity 1 and acceptable intake and limit justification for Lodoxamide Impurity 1. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Lodoxamide Impurity 1

Explore Altox services and software through the Altox Pharma-Hub.